Citation Impact
Citing Papers
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
2006 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Antiepileptic drugs: indications other than epilepsy
2004
Disulfonimide‐Catalyzed Asymmetric Reduction of N‐Alkyl Imines
2015 StandoutNobel
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
How to perform a meta-analysis with R: a practical tutorial
2019 Standout
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain
2016 StandoutNatureNobel
Rivastigmine
1998
Twelve-Month Use of Mental Health Services in the United States
2005 Standout
A Canadian Cohort Study of Cognitive Impairment and Related Dementias (ACCORD): Study Methods and Baseline Results
2003
Alzheimer's disease
2011 Standout
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
2015
Clinical approaches to treatment of Internet addiction
2014 Standout
Age-associated cognitive decline
2009 Standout
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition
2000
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
2004 Standout
Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms
2007
Botulinum Toxin Type A (BOTOX ® ) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial
2005
Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)
2010
Overview of pediatric headache
2004
Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila
2008 StandoutNobel
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
1999 Standout
The World Health Organization's WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A Report from the WHOQOL Group
2004 Standout
Migraine — Current Understanding and Treatment
2002 Standout
Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications: A Randomized Double‐Blind, Placebo‐Controlled Study
2005
Haloperidol versus placebo for schizophrenia
2001
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
1999
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
The projected effect of risk factor reduction on Alzheimer's disease prevalence
2011 Standout
Sexuality and Schizophrenia: A Review
2004
Galantamine
2000
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH
2012 Standout
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
2010 Standout
Non-epilepsy uses of antiepilepsy drugs.
2006
The Importance of Placebo in Headache Research
2008
Measuring the whole or the parts?
2001 Standout
Users' Guides to the Medical Literature
1997
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Immediate and delayed effects of cognitive interventions in healthy elderly: A review of current literature and future directions
2008
Disulfonimid‐katalysierte asymmetrische Reduktion von N‐Alkyliminen
2015 StandoutNobel
Haloperidol versus placebo for schizophrenia
2013
Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society.
1997 Standout
Industry sponsorship and research outcome
2017 Standout
Effectiveness of high‐dose riboflavin in migraine prophylaxis A randomized controlled trial
1998
Works of Christopher Silber being referenced
Sertindole in the treatment of psychosis in schizophrenia
1997
Migraine Prophylaxis With Divalproex
1995
Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
1997